Drug recall D-0821-2021
Product
Naproxen Sodium Tablets, USP 275 mg 100 Tablets Rx Only NDC 68462-178-01 Manufactured by: Glenmark Pharmaceuticals Inc., USA 4147 Goldmine Road Monroe, NC 28110 Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430
Reason for recall
CGMP Deviations
Lots and codes
Lots: 29190087 Exp. 10/31/2021; 29190088 Exp. 10/31/2021; 29190089 Exp. 10/31/2021; 29200077 Exp. 11/30/2022; 29200078 Exo, 11/30/2022
Recall details
- Recalling firm
- Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ
- Quantity
- 9552 bottles
- Distribution
- Nationwide.
- Type
- Voluntary: Firm initiated
- Recall initiated
- August 27, 2021
- Terminated
- October 4, 2023
Related products
- Naproxen Sodium – drug information
- NDC 68462-179 Naproxen Sodium · Naproxen Sodium 550 mg/1 · Glenmark Pharmaceuticals Inc., USA
- NDC 68462-178 Naproxen Sodium · Naproxen Sodium 275 mg/1 · Glenmark Pharmaceuticals Inc., USA
- NDC 68462-189 Naproxen · Naproxen 375 mg/1 · Glenmark Pharmaceuticals Inc., USA
- NDC 68462-188 Naproxen · Naproxen 250 mg/1 · Glenmark Pharmaceuticals Inc., USA
- NDC 68462-190 Naproxen · Naproxen 500 mg/1 · Glenmark Pharmaceuticals Inc., USA